Department of Surgery, University of California, Los Angeles, Los Angeles.
JAMA Surg. 2019 Oct 1;154(10):899-906. doi: 10.1001/jamasurg.2019.2141.
Diverting loop ileostomy and colonic lavage has generated much interest since it was first reported as a potential alternative to total abdominal colectomy for treating Clostridium difficile colitis in 2011. To our knowledge, few studies have validated the benefit reported in the initial description, and the association of this new approach with practice patterns has not been described.
To examine the national adoption pattern and outcomes of diverting loop ileostomy vs total abdominal colectomy as treatment for fulminant C difficile colitis.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used data from hospitals participating in the National Inpatient Sample database across the United States from January 2011 to September 2015 and included 3021 adult patients who underwent surgery for C difficile colitis during the study period, comprising 2408 subtotal colectomies and 613 loop ileostomies. The data were analyzed between November 2018 and April 2019.
Loop ileostomy as surgery of choice.
In-hospital mortality.
Of 2408 participants, 1416 (58.8%) were women, 1781 (78.4%) were white, and 627 (21.6%) were individuals of color and the mean (SD) age was 68.2 (14.8) years. During the overall study period, 613 patients (20.28%) underwent diverting loop ileostomy without total abdominal colectomy. The annual proportion of patients undergoing only diversion increased from 11.16% in 2011 to 25.30% in 2015. Significantly more loop ileostomies were performed within the first day of hospitalization, in contrast to subtotal colectomies (23.31% vs 12.21%; P < .01). There was no significant difference in in-hospital mortality rates between the 2 groups (25.98% vs 31.18%; P = .28).
This study demonstrates the adoption of diverting loop ileostomy to treat C difficile colitis across the United States. While fulminant C difficile colitis remains a condition with high mortality rates, no significant difference in this outcome was observed between loop ileostomy and total abdominal colectomy. Loop ileostomy may represent a viable surgical alternative to total abdominal colectomy, although the grounds for selection of treatment need to be clarified.
自 2011 年首次报道 diverting loop ileostomy 和 colonic lavage 作为治疗艰难梭菌结肠炎的一种潜在替代方法以来,它已引起广泛关注。据我们所知,很少有研究验证了最初描述中报告的益处,并且这种新方法与实践模式的关联尚未描述。
检查 diverting loop ileostomy 与 total abdominal colectomy 作为治疗暴发性艰难梭菌结肠炎的治疗方法的全国采用模式和结果。
设计、地点和参与者:这项回顾性队列研究使用了美国全国住院患者样本数据库中 2011 年 1 月至 2015 年 9 月的数据,包括 3021 名在研究期间接受艰难梭菌结肠炎手术的成年患者,其中包括 2408 例次全结肠切除术和 613 例 diverting loop ileostomy。数据于 2018 年 11 月至 2019 年 4 月进行分析。
loop ileostomy 作为首选手术方式。
住院死亡率。
在 2408 名参与者中,1416 名(58.8%)为女性,1781 名(78.4%)为白人,627 名(21.6%)为有色人种,平均(SD)年龄为 68.2(14.8)岁。在整个研究期间,613 名患者(20.28%)接受了 diverting loop ileostomy 而未行全结肠切除术。仅行分流术的患者比例从 2011 年的 11.16%增加到 2015 年的 25.30%。与次全结肠切除术相比,分流术在住院的第一天进行的比例明显更高(23.31% vs 12.21%;P<0.01)。两组的住院死亡率无显著差异(25.98% vs 31.18%;P=0.28)。
本研究表明 diverting loop ileostomy 在全美范围内被用于治疗艰难梭菌结肠炎。虽然暴发性艰难梭菌结肠炎仍然是一种死亡率较高的疾病,但在 diverting loop ileostomy 和 total abdominal colectomy 之间并未观察到这种结果的显著差异。Loop ileostomy 可能代表 total abdominal colectomy 的一种可行的手术替代方法,尽管需要澄清选择治疗方法的依据。